✦ LIBER ✦

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

✍ Scribed by Cristina Tognon; Stevan R Knezevich; David Huntsman; Calvin D Roskelley; Natalya Melnyk; Joan A Mathers; Laurence Becker; Fatima Carneiro; Nicol MacPherson; Doug Horsman; Christopher Poremba; Poul H.B Sorensen

Book ID: 114413238
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 610 KB
Volume: 2
Category: Article
ISSN: 1535-6108
DOI: 10.1016/s1535-6108(02)00180-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ETV6-NTRK3—Trk-ing the primary event in

ETV6-NTRK3—Trk-ing the primary event in human secretory breast cancer

✍ David M Euhus; Charles F Timmons; Gail E Tomlinson 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A fluorescence in situ hybridization stu

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma

✍ Nikita Makretsov; May He; Malcolm Hayes; Stephen Chia; Doug E. Horsman; Poul H. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract The translocation t(12;15)(p13;q25), in which the __ETV6__ gene from chromosome 12 is rearranged with the __NTRK3__ gene from chromosome 15, has recently been identified in secretory breast carcinoma (SBC). This fusion gene was initially described in congenital fibrosarcoma and congenit

Secretory breast carcinomas with ETV6-NT

Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum

✍ Laé, Marick; Fréneaux, Paul; Sastre-Garau, Xavier; Chouchane, Olfa; Sigal-Zafran 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 429 KB

ETV6–NTRK3 gene fusion in a secretory ca

ETV6–NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual

✍ F. Grabellus; K. Worm; A. Willruth; K.J. Schmitz; F. Otterbach; H.A. Baba; R. Ki 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 369 KB

Cryptic t(12;15)(p13;q26) producing the

Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis

✍ Naoki Watanabe; Hirofumi Kobayashi; Toshinori Hirama; Atsushi Kikuta; Shoichi Ko 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 517 KB

In primary human breast carcinomas mutat

In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high s-phase index

✍ Giorgio R. Merlo; Amelia Bernardi; Francesca Diella; Tiziana Venesio; Alberto P. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 748 KB

## Abstract A series of 121 human breast tumors was screened for point mutations in exons 5 through 8 of the p53 gene, by SSCP analysis. On the same tumor samples, the S‐phase index (SPI) was determined by the incorporation of BUdR in fresh tissue. p53 mutations were observed in 29% of the cases. T